Sign Up to like & get
recommendations!
0
Published in 2019 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-019-04646-4
Abstract: Purpose Despite remarkable clinical responses and prolonged survival across several cancers, not all patients benefit from PD-1/PD-L1 immune checkpoint blockade. Accordingly, assessment of tumour PD-L1 expression by immunohistochemistry (IHC) is increasingly applied to guide patient…
read more here.
Keywords:
tumour models;
pet imaging;
site specifically;
dfo 6e11 ... See more keywords